Kyongbo Pharmaceutical Co Ltd Financial Flexibility Index
Kyongbo Pharmaceutical Co Ltd financial flexibility index. Kyongbo Pharmaceutical Co Ltd (214390) has a Financial Flexibility Index of 0.07x as of June 2026. Free cash flow of ₩16.36 Billion (operating CF ₩-565.17 Million minus capex ₩16.92 Billion) represents 0% of total liabilities (₩220.58 Billion). See cash generation quality of Kyongbo Pharmaceutical Co Ltd to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Kyongbo Pharmaceutical Co Ltd (2014–2025)
Financial flexibility index of Kyongbo Pharmaceutical Co Ltd from 2014 to 2025. Historical Financial Flexibility Index trend for Kyongbo Pharmaceutical Co Ltd across 12 annual periods. Check 214390 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Kyongbo Pharmaceutical Co Ltd Financial Flexibility Index by Year (2014–2025)
Kyongbo Pharmaceutical Co Ltd financial flexibility index by year from 2014 to 2025. Year-by-year free cash flow to debt coverage for Kyongbo Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see Kyongbo Pharmaceutical Co Ltd operating cash flow efficiency.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.28x | ₩49.07 Billion | ₩7.46 Billion | ₩173.80 Billion | ▲ +191.9% |
| 2024 | 0.10x | ₩13.32 Billion | ₩149.12 Million | ₩137.73 Billion | ▼ -25.0% |
| 2023 | 0.13x | ₩15.72 Billion | ₩4.84 Billion | ₩121.92 Billion | ▼ -46.4% |
| 2022 | 0.24x | ₩23.31 Billion | ₩10.13 Billion | ₩96.84 Billion | ▼ -39.5% |
| 2021 | 0.40x | ₩36.29 Billion | ₩17.97 Billion | ₩91.28 Billion | ▲ +16.3% |
| 2020 | 0.34x | ₩33.23 Billion | ₩20.80 Billion | ₩97.18 Billion | ▼ -35.4% |
| 2019 | 0.53x | ₩46.91 Billion | ₩23.67 Billion | ₩88.65 Billion | ▲ +444.5% |
| 2018 | 0.10x | ₩7.06 Billion | ₩-1.14 Billion | ₩72.61 Billion | ▼ -81.5% |
| 2017 | 0.52x | ₩33.20 Billion | ₩25.81 Billion | ₩63.36 Billion | ▼ -13.5% |
| 2016 | 0.61x | ₩45.01 Billion | ₩25.33 Billion | ₩74.33 Billion | ▲ +39.7% |
| 2015 | 0.43x | ₩31.50 Billion | ₩4.24 Billion | ₩72.67 Billion | ▲ +22.4% |
| 2014 | 0.35x | ₩35.32 Billion | ₩16.04 Billion | ₩99.70 Billion | — |